Ann: PKS signs new agreement with SA Pathology, page-3

Yes, nice to see a win with such a significant pathology provider. A bit surprised the market reaction wasn't stronger. Perhaps the market is disappointed with the contract value, at up to $314k per annum? I'm not too fussed, this should be mostly profit given their software margins.

Also I think it's possible SA Pathology is just testing the waters first with a smaller initial outlay, with a view to expanding its use after 12 months if it performs as expected. The health profession tends to be averse to changes, and changing clinical decision making processes must be a pretty big deal for a pathology lab. Would make sense to sort of ease into it.

I'm encouraged by the heft of the latest client win - should catch the attention of other large path labs, and maybe make them take a closer look at RippleDown.